Role of the hypothalamus in the neuroendocrine regulation of body weight and composition during energy deficit.
Level 5 - mechanism / opinion, no new human data
Narrative review synthesizing mechanistic animal and human literature without systematic review methodology
PubMed 22070225 · doi:10.1111/j.1467-789X.2011.00948.x
What was done
This narrative review synthesized evidence from animal and human studies to evaluate the effect of negative energy balance on hypothalamic neuropeptides (such as neuropeptide Y, agouti-related peptide, alpha-melanocyte-stimulating hormone, and cocaine- and amphetamine-regulated transcript) and neuroendocrine axes regulating body weight and composition.
What was found
No quantitative data or effect sizes are reported in the abstract. Qualitatively, energy deficit in lean and obese models consistently inhibits the hypothalamo-pituitary-thyroid, -gonadotropic, and -somatotropic axes (decreasing circulating insulin-like growth factor-1) while activating the hypothalamo-pituitary-adrenal axis. These changes are noted to stimulate appetite, decrease energy expenditure, promote adipose accumulation (especially central adiposity), and accelerate lean body mass and bone loss.
Why it matters
Calorie restriction protocols aimed at weight reduction may unintentionally trigger neuroendocrine counter-regulations that exacerbate long-term risks of sarcopenia, osteoporosis, and rebound central obesity.
Limits
The abstract describes a broad narrative synthesis without systematic search criteria, quality appraisal, or pooled statistical estimates. Sample sizes and study designs are not reported. Much of the specific hypothalamic signaling evidence is derived from animal models rather than robustly quantified human clinical trials.
Cited by
- supports When fat mass is lost, shrinking adipocytes decrease leptin secretion, signaling the brain to stimulate appetite.